FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
CNET11h
6 Vitamins and Minerals You Need to Age Gracefully, According to Experts
To make sure your body is in tip-top shape as you age, make sure you're getting these vitamins and minerals in your diet or ...
Top5 on MSN13h
Your Guide to Mushroom Supplements
Welcome to our comprehensive review of mushroom supplements, where we delve deep into the world of these natural health ...
FDA approves standalone use of J&J's ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...
Harvard Medical School18h
Drawing a Line From the Gut Microbiome to Inflammation and Depression
Biochemical analyses provide an answer to the question of how the gut bacterium Morganella morganii might contribute to some ...
Hosted on MSN20h
The Best Time to Take Magnesium Supplements for Optimal Health
Medically reviewed by Alex Yampolsky, PharmD Magnesium is needed for various body functions, including producing energy, bone ...